MoneyWorks4Me

The total revenue for the quarter ended March 2026 remained nearly unchanged at Rs. 3383.72 millions.Profit after Tax for the quarter ended March 2026 saw a decline of -44.92% from Rs. 275.89 millions to Rs. 151.97  millions.The company reported a degrowth in operating Profit to 395.16 millions from 497.74 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 3383.72 3287.53 2.93 13487.36 13117.84 2.82 13487.36 13117.84 2.82
Other Income 277.29 320.50 -13.48 1129.65 1241.92 -9.04 1129.65 1241.92 -9.04
PBIDT 395.16 497.74 -20.61 2104.25 2626.91 -19.90 2104.25 2626.91 -19.90
Interest 25.93 26.26 -1.26 100.38 153.09 -34.43 100.38 153.09 -34.43
PBDT 342.12 471.48 -27.44 1938.68 2473.82 -21.63 1938.68 2473.82 -21.63
Depreciation 124.21 100.93 23.07 455.03 395.45 15.07 455.03 395.45 15.07
PBT 217.91 370.55 -41.19 1483.65 2078.37 -28.61 1483.65 2078.37 -28.61
TAX 65.94 94.66 -30.34 367.25 468.39 -21.59 367.25 468.39 -21.59
Deferred Tax 33.28 12.05 176.18 -3.69 -7.14 -48.32 -3.69 -7.14 -48.32
PAT 151.97 275.89 -44.92 1116.40 1609.98 -30.66 1116.40 1609.98 -30.66
Equity 306.21 306.21 0.00 306.21 306.21 0.00 306.21 306.21 0.00
PBIDTM(%) 11.68 15.14 -22.87 15.60 20.03 -22.09 15.60 20.03 -22.09

Akums Drugs & Pharma Share Price

752.40 8.70 (1.17%)
19-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1898.00
Dr. Reddys Labs. 1171.00
Cipla 1416.00
Lupin 2220.00
Zydus Lifesciences 1105.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: